K+S

A tricky 2020 expected

13/01/20 -"We have slightly revised our view on k+s, especially on our cash flow assumptions as we now expect a lower contribution to the balance sheet. We also have a more moderate view on the company’s ..."

PDF page sample
Pages
53
Language
English
Published on
13/01/20
Download
You may also be interested by these reports :
22/06/26
BASF (Reduce, Germany) is one of the world’s largest chemical companies, representing chemistry at a scale that very few can match. The company’s ...
18/06/26
The adjustment of our numbers stems from the free share attribution ( as happens every second year). For all shareholders: 1 free share for 10 ...
17/06/26
The lower EPS forecast reflects a more cautious view on 2026. We have cut our FY2026 and FY2027 EBITDA estimates by ~4% and ~3%, respectively, to ...
03/06/26
K+S announced the acquisition of the salts business from Qemetica for €350m, plus a potential €30m earn-out. While the deal values the assets at ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO